Thyroid cancer is generally associated with very high survival rates. The prognosis for thyroid cancer is often favorable, with the majority of patients surviving the disease. Survival rates can vary depending on the specific type and stage of thyroid cancer. Here are some general survival rate statistics: Papillary Thyroid Cancer: Papillary thyroid cancer, the most common type, has a high survival rate. The 5-year relative survival rate for localized papillary thyroid cancer is approximately 99%, meaning that almost all patients with localized disease are alive 5 years after diagnosis. Even for regional (spread to nearby lymph nodes) or distant (metastatic) disease, the 5-year survival rate remains relatively high at around 93%. Follicular Thyroid Cancer: Follicular thyroid cancer also has favorable survival rates. The 5-year relative survival rate for localized disease is approximately 97%. For regional disease, it's about 86%, and for distant disease, it's around 67%. Medullary Thyroid Cancer: Medullary thyroid cancer has slightly lower survival rates compared to papillary and follicular types. For localized disease, the 5-year relative survival rate is around 98%. For regional disease, it's about 89%, and for distant disease, it drops to approximately 41%. Anaplastic Thyroid Cancer: Anaplastic thyroid cancer is the most aggressive form of thyroid cancer, and survival rates are much lower. The 5-year relative survival rate for this type is generally less than 10%, and many cases are fatal.
An estimated 1,590 people will die of thyroid cancer during 2009. Thyroid cancer is, however, considered one of the least deadly and most survivable cancers, and 5-year survival rates for thyroid cancer is almost 97%. For more information on this cancer please visit http://thyroid.about.com/od/thyroidcancer/a/neckcheck.htm
An estimated 1,590 people will die of thyroid cancer during 2009. Thyroid cancer is, however, considered one of the least deadly and most survivable cancers, and 5-year survival rates for thyroid cancer is almost 97%. For more information on this cancer please visit http://thyroid.about.com/od/thyroidcancer/a/neckcheck.htm
The thyroid is located right below the adam's apple, at the base of the neck. The thyroid's main function is to create hormones that regulate the body's temperature, weight and metabolism, heart rate, and blood pressure. Thyroid cancer occurs when the cells in the thyroid mutate and become cancerous. The cause of thyroid cancer is unknown, however, there are risk factors that make some people more susceptible to developing it. Also, thyroid cancer symptoms can be hard to spot, and are only noticed when the disease has progressed. The chances of women getting thyroid cancer is three times more likely than men. Having a family history of goiter, which is the enlargement of the thyroid gland, can cause a person to be at risk of getting thyroid cancer. Another risk factor is if there is a history of having thyroid cancer in the family. Also, being exposed to radiation at high levels have shown to cause thyroid cancer. Older people and Caucasians are more likely to get thyroid cancer than any other age or race. Although thyroid cancer does not manifest with many signs and symptoms during the early stages, as it gets larger, there are several symptoms that show up. As the tumor grows, it can press on the voice box and cause hoarseness or other voice changes. People can also experience difficulty in swallowing, and often accompanied by pain in the throat or neck. Thyroid cancer can also be detected when a person notices a nodule or visible bump on their neck. Because thyroid cancer is not common in the United States, doctors will most likely try to find other reasons for the symptoms. If thyroid cancer is suspected, a biopsy is done to the nodule to determine if it is benign or is indeed cancerous. When the symptoms do point to thyroid cancer, the customary treatment is surgery. Radiation therapy and chemotherapy are other treatments that are used. If the cancer has not spread, there is a large chance of success. Survival rates vary depending on how large the tumor was, the person's age, and whether it has spread. For the most part, long-term survival rates are high for people who develop thyroid cancer.
Colon cancer survival rates vary greatly depending on which stage the cancer is in when diagnosed. On average, a typical 5-year survival rate is between 55% and 63%.
It is possible to survive colon cancer. Cases that are diagnosed early have a much better 5 year survival rate. This is why it is recommended that people get colonoscopies periodically.
Ovarian cancer can be treated with rounds of chemotherapy. The earlier the treatment, the greater the chance of survival. Stage 1 of the cancer has a 90 percent survival rate, while stage 4 only has a survival rate of 10 percent.
The 5-year survival rate for colon cancer is around 65-70%. However, survival rates can vary depending on the stage at diagnosis and individual factors. Early detection and treatment can greatly improve outcomes.
There many advanced methods that are now making prostate cancer's survival rate better. They have advanced drugs to deal with this disease. They also have better chemos and radiation to help kill the cancer cells.
Do you mean prostate cancer that has spread to the bone? Or survival rates for prostate cancer versus bone cancer? In the case of the former, I believe the prognosis is bad. The highest 10 year survival rates (http://longevity.about.com/od/longevityandillness/a/prostate_le.htm) for prostate treatment is a prostatectomy (surgical prostate removal), but if the cancer has already spread to the bone then prostate removal will not solve the problem, because the cancer has already metastasized. In the case of the latter, there are different demographics and different subtypes of cancer to compare! This, combined with different treatment options, dramatically affects the survival rate.
The survival rate for cervical cancer in the United States is found that 82% of women in the US have a five year survival rate, versus the 73% chance of survival from when in Europe, based on the 2000-02 study by Eurocare, found here: http://www.ncbi.nlm.nih.gov/pubmed/17714993
Cancer patients who take astragalus during or after cancer treatments tend to recover more quickly from the ill effects of the treatment, and they generally have better survival rates.